Vermon SA, a leading innovator in ultrasound transducer technologies, has announced the appointment of Bertrand Boutaud as its new Chief Executive Officer, effective immediately.
Boutaud, a seasoned entrepreneur, brings more than two decades of experience in international and demanding MedTech environments. Known for his expertise in leading multidisciplinary teams through periods of rapid business and industrial growth, he is expected to play a pivotal role in driving Vermon’s next phase of innovation and expansion.
Etienne Flesch will continue in his role as Chairman of Vermon, ensuring continuity of strategic vision while guiding the company’s long-term growth.
Commenting on his appointment, Bertrand Boutaud said:
“Joining VERMON as CEO is a privilege. This company is renowned for its innovative spirit and commitment to excellence. I'm eager to collaborate with our talented teams to advance our vision and deliver exceptional value to our clients and partners.”
Etienne Flesch, Chairman of Vermon, added:
“Bertrand's appointment as CEO marks a pivotal step for VERMON SA. His leadership and expertise will open up new horizons for us, while I continue to guide our strategy as Chairman.”
With Boutaud at the helm, Vermon reaffirms its commitment to developing cutting-edge ultrasound transducer technologies, strengthening its position at the forefront of MedTech innovation.
Reference: https://vermon.com/
